Stem cells aim to restore ovarian function in early trial
NCT ID NCT07551895
First seen Apr 29, 2026 · Last updated Apr 29, 2026
Summary
This early-phase trial tests a stem cell injection (HS_SW01) in 21 women with primary ovarian insufficiency (POI), a condition where the ovaries stop working before age 40. The main goal is to check safety and see if the treatment can improve hormone levels related to ovarian function. Participants must not plan to become pregnant during the study.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY OVARIAN INSUFFICIENCY (POI) are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.